Cervo L, Samanin R
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Pharmacol Biochem Behav. 1995 Dec;52(4):671-6. doi: 10.1016/0091-3057(95)00189-4.
Drugs with different intrinsic activity at 5-HT1A receptors and antagonists at 5-HT2A/2C and 5-HT3 receptors were studied for their ability to increase the rates of punished operant responding in rats. Like chlordiazepoxide (5 and 10 mg/kg) and diazepam (1.25 and 2.5 mg/kg), 0.125 mg/kg 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a 5-HT1A receptor agonist, and 5 and 10 mg/kg ipsapirone, a partial agonist at these receptors, increased the rates of punished responding, whereas (S)-WAY 100135, a 5-HT1A receptor antagonist, had no effect at doses from 1 to 10 mg/kg. 8-OH-DPAT and ipsapirone, like benzodiazepines, significantly reduced unpunished responding. The 5-HT2A/2C receptor antagonists ritanserin (2 mg/kg), mianserin (8 mg/kg), and mesulergine (0.1 mg/kg) significantly increased the rates of punished responding, whereas 0.5-2 mg/kg ketanserin, that has higher affinity for 5-HT2A than 5-HT2C receptors, had no effect. Antagonists, at 5-HT3 receptors such as ondansetron (0.001-0.1 mg/kg) and tropisetron (0.001-0.1 mg/kg), had no effect on punished or unpunished responding. The results show that agents acting as full or partial agonists at 5-HT1A receptors and blockers of postsynaptic 5-HT2C receptors have anxiolytic-like effects in a model of punished operant responding, whereas antagonists at 5-HT1A and 5-HT3 receptors have no such effect.
研究了对5-HT1A受体具有不同内在活性且对5-HT2A/2C和5-HT3受体有拮抗作用的药物,观察它们增加大鼠受罚操作性反应率的能力。5-HT1A受体激动剂0.125mg/kg的8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)以及这些受体的部分激动剂5mg/kg和10mg/kg的ipsapirone,与氯氮卓(5mg/kg和10mg/kg)及地西泮(1.25mg/kg和2.5mg/kg)一样,增加了受罚反应率,而5-HT1A受体拮抗剂(S)-WAY 100135在1至10mg/kg剂量时无作用。8-OH-DPAT和ipsapirone与苯二氮卓类药物一样,显著降低了未受罚反应。5-HT2A/2C受体拮抗剂利坦色林(2mg/kg)、米安色林(8mg/kg)和美舒麦角(0.1mg/kg)显著增加了受罚反应率,而对5-HT2A受体亲和力高于5-HT2C受体的0.5 - 2mg/kg酮色林则无作用。5-HT3受体拮抗剂如昂丹司琼(0.001 - 0.1mg/kg)和托烷司琼(0.001 - 0.1mg/kg)对受罚或未受罚反应均无作用。结果表明,在受罚操作性反应模型中,作为5-HT1A受体的完全或部分激动剂以及突触后5-HT2C受体阻滞剂的药物具有抗焦虑样作用,而5-HT1A和5-HT3受体拮抗剂则无此作用。